Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2023

Phase I trial methodology

Pharmacodynamic endpoints in FIH trials

Date

07 Mar 2023

Session

Phase I trial methodology

Topics

Clinical Research;  Translational Research;  Molecular Oncology;  Therapy

Tumour Site

Presenters

Udai Banerji

Authors

U. Banerji

Author affiliations

  • Drug Development Unit  , The Institute of Cancer Research and Royal Marsden Hospital, SM2 5PT - Sutton/GB

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.